
### [NCIT:C7749](http://purl.obolibrary.org/obo/NCIT_C7749)
**Label:** Cutaneous Fibrohistiocytic Neoplasm

**Subclasses:** [NCIT:C6801](http://purl.obolibrary.org/obo/NCIT_C6801) (Cutaneous Fibrous Histiocytoma), [NCIT:C49078](http://purl.obolibrary.org/obo/NCIT_C49078) (Cutaneous Fibrous Histiocytoma, Cellular Variant), [NCIT:C49076](http://purl.obolibrary.org/obo/NCIT_C49076) (Cutaneous Fibrous Histiocytoma, Fibroblastic Variant), [NCIT:C7344](http://purl.obolibrary.org/obo/NCIT_C7344) (Intermediate Cutaneous Fibrohistiocytic Neoplasm), [NCIT:C7343](http://purl.obolibrary.org/obo/NCIT_C7343) (Benign Cutaneous Fibrohistiocytic Neoplasm), 

**Class expressions from DL-Learner:**

- Thing 52.40%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 42.65%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 40.91%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 40.91%


